Delivery Order SPE2DB20D1100-SPE2DB25FA3T3

Award Date 1/30/25
Potential Completion Date 1/31/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024 with a ceiling value of $2,057.50. It is a firm fixed-price delivery order contract with a completion date of December 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FDVM1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of AZSTARYS 26.1 MG-5.2 MG CAP 100S, a pharmaceutical product, with a ceiling value of $4,893. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical...
This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN50L, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,437.77 firm fixed-price delivery order is for the supply of AZSTARYS 52.3 MG-10.4 MG CAP 100S, a pharmaceutical product. The contract has a completion date of February 7, 2025 and was awarded on February 6, 2025. This award is not associated with a set-aside program....
This federal contract award, valued at $2,664.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including specialty,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,088.34, is a delivery order for pharmaceutical and medical supplies to support military healthcare programs. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This single-award...
This federal contract award, valued at $22,643.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award, valued at $1,017.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the provision of a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award, valued at $1,345.36, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order for the supply of various pharmaceutical products and medical supplies, including specialty medications, generic drugs, and medical equipment such as syringes and test kits. This award is a part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $2,167.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the Defense Logistics Agency Troop Support Medical Indefinite Delivery Contract (IDC), which has a total potential value of $999,999,999 and provides a range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This federal contract award, valued at $179,808.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. The award covers a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA3T3
    Delivery Order

This federal contract award, valued at $2,035.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AZSTARYS 26.1 MG-5.2 MG CAP 100S, a prescription medication, to support federal healthcare programs.

The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/4/25, 12:59 AM